Task: Answer the multiple-choice question.
Question: Which drug exhibits a 17.550% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] CCCC(CCC)C(=O)Nc1cccc(-c2cn3c(n2)SCC3)c1
[b] O=C(O)CCC(=O)Nc1ccc(C(=O)OCC(=O)c2ccc(Cl)cc2)cc1
Answer: a. CCCC(CCC)C(=O)Nc1cccc(-c2cn3c(n2)SCC3)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCC(CCC)C(=O)Nc1cccc(-c2cn3c(n2)SCC3)c1
CCCC(CCC)C(=O)Nc1cccc(-c2cn3c(n2)SCC3)c1
N-[3-(2,3-dihydroimidazo[2,1-b][1,3]thiazol-6-yl)phenyl]-2-propylpentanamide